Bildkälla: Stockfoto

Medivir: Rights Issue Subscribed to 87% - Redeye

Redeye comments on the outcome of Medivir’s rights issue.

Redeye comments on the outcome of Medivir’s rights issue.
Börsvärldens nyhetsbrev
ANNONSER